bluebird bio inc
(BLUE:Consolidated Issue Listed on NASDAQ Global Select )
Chief Executive Officer, President and Director, bluebird bio, Inc.
|Age||Total Calculated Compensation||This person is connected to 14 board members in 1 different organizations across 3 different industries.|
See Board Relationships
As of Fiscal Year 2014
Mr. Nick Leschly has been Chief Executive Officer and President at bluebird bio, Inc. (alternate name Genetix Pharmaceuticals Inc.) since September 2010. Mr. Leschly served as Interim President at bluebird bio, Inc. until September 2010. He served as Partner at Third Rock Ventures, LLC. He served as the Chief Business Officer of Agios Pharmaceuticals, Inc. Prior to joining Third Rock, he served as the product and alliance leader for Millennium Pharmaceuticals VELCADE™, ...
150 Second StreetPhone: 339-499-9300
Cambridge, Massachusetts 02141
Board Members Memberships*
Chief Executive Officer, President and Director
University of Pennsylvania - The Wharton School
|Edward O. Lanphier II||Founder, Chief Executive Officer, President, Director and Member of Clinical Review Committee|
Sangamo Biosciences Inc.
|David M. Pernock||Chairman of the Board, Chief Executive Officer and President|
Fibrocell Science, Inc.
|$490.0K||Compensation as of Fiscal Year 2014.|